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Medication Safety in Oncology Care: Mapping Checking
Procedures From Prescription to Administration
of Chemotherapy
Yvonne Pfeiffer, Stephan S. Gut, and David L.B. Schwappach
QUESTION ASKED: How many and which
types of medication checks are performed along
the lifecycle of a prescription fromprescribing to
administration of chemotherapy?
SUMMARY ANSWER: Checking is consid-
ered an important activity to enhance medi-
cation safety. However, we found that number
and types of checking procedures vary with
professional groups, hospitals, units, and ad-
ministration routes. Compared with pharmacy
staff, nurses and physicians have a lot of var-
iation and little consistency in the number and
types of checks applied for the same medica-
tion phases across hospitals, between different
administration routes, and between units and
wards (even within a given hospital).
WHATWEDID: Fromdocument analysis and
interviews, we assessed all checking procedures
applied by nurses, physicians, and pharmacists
from prescription to administration. Therefore,
we differentiated between three types of activ-
ities: (1) single and (2) double checks—two
sources of information were compared against
each other once or twice, (eg, prescription v
drug) and (3) plausibility reviews—someone
used his or her own knowledge to examine a
prescription. We also developed a mapping
approach to illustrate and compare the checks
performed along three phases of themedication
process (prescription, production/preparation,
and administration) in three hospitals, and we
differentiated by administration routes (in-
travenous v oral) and organizational units (ward
v ambulatory infusion units). In the mapping
approach, a check is represented by a box, and
the type of check is described within the box;
the line stands for the medication process, and
colors indicate the hospital. Our evaluation
scheme to categorize checks and the mapping
approach was feasible and understandable for
practitioners.
WHATWE FOUND: The mapping approach
illustrates the checks performed and allows
for a better understanding and overview of the
checks applied in the whole medication pro-
cess. Single checks were common for nurses
right before intravenous administration, and
they performed double checks at various points
in the medication process—most often before
administration. According to our assessment,
senior physicians usually applied plausibil-
ity reviews on prescriptions of resident phy-
sicians. In the pharmacy, we found the most
detailed documentation of checking procedures
and themost standardizedcheckingprocedures.
BIAS, CONFOUNDING FACTOR(S), REAL-
LIFE IMPLICATIONS: We focused on existing
checks in themedicationprocess, soour analysis
did not allow conclusions about missing but
potentially beneficial checks. Furthermore, we
did not assess the actual checking behavior, so
we cannot draw conclusions about compliance
rates. Assessment and comparison of the use of
specific safety activities, such as checking pro-
cedures, generate useful results for practitioners
and researchers alike. The proposed mapping
approach visualizes the check processes in
current oncologic practice to better understand
and improve them. However, it will not guide
the decision about when to introduce checks.
The medication hazards should be analyzed
carefully, and the checks should be located at
points in the process that aremost vulnerable to
errors.
ReCAPs (Research
Contributions Abbreviated for
Print) provide a structured,
one-page summary of each
paper highlighting the main
ﬁndings and signiﬁcance of
the work. The full version of
the article is available online at
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Abstract
Purpose
To increasemedicationsafety inoncology, checkingprocedures are increasinglyappliedby
nurses, physicians, andpharmacists. However, little is knownabout thenumber, types, and
consistency of implemented checks. The aim of the study was to assess the number and
types of different checking procedures that are performed along the lifecycle of a
chemotherapy prescription across three hospitals, different care settings, administration
routes, and professional groups.
Methods
Ascheme toevaluate checkingprocedures andamappingapproach to illustrate the checks
along the phases of the medication process were developed. Checking procedures were
assessed on the basis of analysis of internal guidelines and interviews with nurses and
physicians who work on wards and in ambulatory infusion units of three hospitals.
Results
There were considerable differences in number and type of checking procedures among
administration routes, professional groups, wards and ambulatory infusion units, and
hospitals. During the prescribing phase, the lowest number of checks was performed. In
internal guidelines, checking procedures were documented poorly, though the pharmacy
process was an exception.
Conclusion
In contrast to the pharmacists, nurse and physician clinician checking procedures are less
standardizedwithin and across hospitals. The results point to different checking habits for
the professional groups; for example, physicianswould rather performplausibility reviews
than checks. Our evaluation scheme to categorize checks and the visualized mapping
approach was feasible and understandable for practitioners.
INTRODUCTION
Cancer care is provided in a complex en-
vironment. Hazards in the medication
process often are addressed by imple-
mentation of human checks and—if
available—barcode scanning checks. Ad-
dition of a check to themedication process
aims to introduce a safety barrier (ie, a
redundancy that is expected to capture
potential errors before administration). To
augment the effect of a checking pro-
cedure, human double checking is applied
increasingly in health care; it is expected
that four eyes see more than two (ie, find
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more errors). Double checking can help identify medication
errors,1 and this is probably the reason for its widespread use.
However, prior research and safety theories discuss important
weaknesses of double checking as a safety strategy: (1) its
effectiveness has not been demonstrated yet2; (2) two checks
may cause both checkers to pay less attention3; (3) both
checkers may have the same blind spots because of their
cognitive processing or disturbances in their environment and
thus oversee the same errors for the same reasons; and (4) as
reported by oncology nurses, double checking can lead to
increased interruptions in workflows.4
Interestingly, even though checking procedures generally
are considered a useful safety strategy for the clinical carework
processes, their actual execution is usuallynot trained,5 nor are
the checking procedures and items to be checked defined.
There is huge variation in double checks performance in
practice, and the checking procedures differ across hospitals,
across hospital units, and among professional groups.4,5
Furthermore, what constitutes an independent (ie, high-
quality) double check is not consistently understood.5,6 Not
onlydoes the typeof checking procedures vary immensely, but
the number of checks performed does also. Griffin et al7 found
far more checks for intravenous (IV) than for oral chemo-
therapy (57 v six checks). In current practice, eachprofessional
group introduces checks into their medication process de-
pendent on their ownwork demands and experiences (eg, past
errors), in isolation from what other professional groups may
check on the samemedication.As a result, implemented safety
measuresmay cluster at some stages or around some potential
errors, but not all relevant risks along the lifecycle of a pre-
scription are captured. To have an overview of applied
checking procedures in the medication process from pre-
scription to administration, processmapping is a valuable tool.
It allows assessment of the checking procedures that different
professional groups apply.8,9 Mapping provides an illustrative
overview of relevant steps of a process—in this case, these
steps are the checks—and brings together information that is
otherwise not easy to grasp simultaneously.
In this study, we examined all checks along the chemo-
therapy medication process from prescription to adminis-
trationof thedrug.Themajoraimwas toassess thenumberand
types of checks applied from chemotherapy prescription to its
administration. We wanted to (1) compare the checks among
three hospitals, with ambulatory and inpatient settings, as well
as between administration routes (IV, oral, and intrathecal);
(2) investigate differences among professional groups in types
andnumberof checksapplied; and(3)get aholisticoverviewof
when checks occur along the medication process phases.
METHODS
Sample
Three hospitals (two teaching hospitals and one regional
hospital) participated in the study; hereafter, they are termed
red, blue, and green hospitals. Each hospital contributed one
oncologicward, the ambulatory infusion unit, and the hospital
pharmacy.We analyzed documents about the work processes
(eg, internal guidelines) for descriptions of checking pro-
cedures. In addition, a physician and a nurse for each ward or
ambulatory unit and a pharmacist for each hospital pharmacy
answeredquestions about checkingprocedures in an interview
setting. Thus, 15 people total (n = 3 pharmacists, n = 6 phy-
sicians, and n = 6 nurses) took part as information sources in
the study. The interviewed professionals were experienced in
their domain and unit, and the pharmacists were familiar with
chemotherapy production.
Data Gathering and Analysis
We analyzed documents and guidelines about the medication
(production)process thatwereceived fromthenursingexperts
of the oncology departments and from the pharmacists. We
asked the interviewees for additional documents tomake sure
thatwecoveredall the availabledocumentation.Wedeveloped
interview guides to assess the checks along the work processes
adapted foreachprofessionalgroup.Wewent throughallof the
steps of the medication process together with the interviewee
to assess all checkingprocedures, even if the intervieweewould
not label them as such. The interviews were conducted in the
person’s work environment to show us how they performed
certain checks, if required. We deliberately asked for the
process as designed and did not focus on potential compliance
issues. We assessed the work processes from the document
analysis, described them, and later categorized them
according to our scheme. The interviews were conducted by a
pharmacist and a trained work psychologist. Before the in-
terviews, we brought together all information from interviews
and documents and mapped the checks for each hospital and
administration route to develop a mapping approach that
allowed comparison of the routes, the phases, and the hos-
pitals. With these mapped processes, we asked our in-
terviewees if their information was assessed correctly and
whether they deemed the maps understandable. This data
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validation was done via e-mail and a reminder; we reached a
100% response rate. After integration of the feedback, we
analyzed the final process maps that displayed all checks.
Definitions and Evaluation Scheme for Checking
Procedures
To evaluate the checks along the medication process, we
developeda scheme toguideourdata analysis.We first defined
criteria to evaluate types of checking procedures: A procedure
was only called a check if information from two sources was
compared (eg, a prescription v a labeled chemotherapy drug,
or the prescription from the physician software tool v the
prescription that was manually transferred into the nursing
software tool). If, for example, a prescription was checked
against a clinician’s own knowledge, not against another
physical source of information,we defined this as a plausibility
review.Wedifferentiated the number of checks performed (ie,
whether it was a single or a double check) and whether the
double-checking procedure involved one person or two
people. A technologically supported check was defined as a
single-person check with technologic support if it was con-
ducted as a barcode scanning procedure. We also differen-
tiated among IV, oral, and intrathecal routes of administration
in our scheme so that we could compare practices by ad-
ministration route.
Mapping of Checks Along the Medication Process
To locate the checks along the course of the medication
process, we assigned them to three phases: First, the pre-
scription phase, which incorporates mainly physician work.
The second phase is the production of the chemotherapy drug,
mainly conducted by pharmacists. For oral chemotherapy, we
called this phase preparation, because the tablets are not ac-
tually produced. The third and last phase is the administration
of the drug, inwhichmainly the nurses are involved. Themain
challenge for mapping the checks throughout the process was
todevelopavisualization thatallowedacomparisonamongthe
hospitalsdespite theirdifferentworkprocesses.Afterwepulled
together all of the relevant information on the checks from the
interviewsandthedocuments,wemappedthechecksalongthe
medicationprocess for each hospital, for ambulatory units and
wards, and for IV and oral drugs. To maximize comparability
and readability, we decided to focus our map solely on the
actual checks performed and to omit all other process steps,
such as patient consultation with the physician or the delivery
of the drug.
RESULTS
All maps to visualize the checking procedures along the
medication process were validated by the interviewed pro-
fessionals andwere considered understandable. Figures 1A-1D
present the results of our analyses. Each route of admin-
istration is presented along the three medication process
phases.
Types of Checks Along the Medication Process
In all threehospitals, therewereno single-persondouble check
and no technology-based check. Single checks were common
for nurses right before IV administration, and double checks
were performed at various points in themedication process—
most often after production or preparation and before
administration.
According to the criteria in our scheme, physicians did not
apply any checks except the final check before intrathecal
administration in two hospitals (Fig 1C). All other checking-
like procedures by physicians were plausibility reviews. For
example, a senior physician performed plausibility reviews on
the resident physician prescriptions. In some units, the res-
ident physician prescriptions were not systematically checked
(oral chemotherapy in red hospital and all chemotherapies in
ambulatory infusion unit of green hospital; Figs 1A and 1B). In
the ambulatory infusion unit of the greenhospital, the resident
physicians were supposed to ask for a review by a senior
physician if they were unexperienced or felt unsure. However,
on the oncologic ward of the same hospital, all resident
physician prescriptions were checked systematically by a
senior physician. We did not separately display a second
plausibility review of the prescription by a senior physician
that was done at the day of the first IV administration in the
ambulatory infusion unit in the blue hospital only.
During the production phase in the pharmacy, there were
two or three single checks of the production materials. These
were labeled single checks, because the sources of information
for the production materials comparison varied (eg, a pro-
duction list or the prescription). Before the chemotherapy was
dispensed, there was a standardized approval of the produced
chemotherapy through a pharmacist.
Number of Checks
The number of checks differs considerably among the hos-
pitals, among thephases of themedicationprocess, andamong
administration routes. During the prescription phase, the
lowest number of checks was performed; in particular,
Copyright © 2018 by American Society of Clinical Oncology jop.ascopubs.org 3
Mapping of Checking Procedures in Chemotherapy
Downloaded from ascopubs.org by ASCO on March 6, 2018 from 066.102.234.242
Copyright © 2018 American Society of Clinical Oncology. All rights reserved.
Prescription
SP: PR of prescription
if done by RP  
SP : PR of prescription
if done by RP1 
Red hospital 
Blue hospital 
Green hospital
P
re
sc
ri
p
ti
o
n
/c
o
n
ti
n
u
at
io
n
 o
f
ch
em
o
th
er
ap
y 
b
y 
o
n
co
lo
g
is
t 
Physician + nurse: DC, final
check of cth at bedside  
A
d
m
in
is
tr
at
io
n
 o
f 
IT
H
 c
h
em
o
th
er
ap
y 
Administration of ITH chemotherapy
D
el
iv
er
y 
o
f 
p
ro
d
u
ce
d
 
IT
H
 c
h
em
o
th
er
ap
y 
In green hospital no ITH chemotherapy is
administered in the ambulatory infusion unit.
Physician + nurse: DC, final
check of cth at bedside  
ITH chemotherapy, ambulatory infusion units
The procedures for prescription and production are the same as for IV chemotherapy (see above).
Administration of IV chemotherapy
Nurse: SC of chemotherapy
after delivery 
Nurse + nurse: DC of cth
before administration  
Nurse: SC, final check
of cth at bedside 
Nurse: SC, final check
of cth at bedside 
Nurse: SC, final check
of cth at bedside A
d
m
in
is
tr
at
io
n
 o
f 
IV
ch
em
o
th
er
ap
y 
D
el
iv
er
y 
o
f 
p
ro
d
u
ce
d
 IV
ch
em
o
th
er
ap
y 
Production
Nurse + nurse: DC of
labels and production
materials 
Pharmacist: PR of 
prescription
Pharmacist: PR of 
prescription
Pharmacy employee: 
SC of production 
materials 
Pharmacy employee: 
SC of production 
materials 
Pharmacy employee: 
SC of production 
materials 
Pharmacy employee: 
SC of production 
materials
Pharmacist: SC of 
produced chemotherapy 
Pharmacist: SC of 
produced chemotherapy 
Nurse: PR of prescription
A
Fig1. Mappingofmedicationcheckprocesses. (A) Intravenous (IV) chemotherapy, ambulatory infusionunits.Note that, ingreenhospitals, no intrathecal (ITH)
chemotherapy is administered in the ambulatory infusion units. (B) Oral chemotherapy, ambulatory infusion units. (C) Intravenous chemotherapy, inpatient
settings (wards). (D) Oral chemotherapy, inpatient settings (wards). CTh/cth, chemotherapy; DC, double check: two sources of information (references) are
compared two times, either by one (single-person double check) or by two qualified health careworkers (eg, one person reads information from the IV bag label
while the secondcompareswith theprescription; then theychange roles and thesecondchecks theprescriptionwhile the first reads information fromthe label);
PR, plausibility review: the check is performed with personal knowledge and experiences instead of comparison of two physical sources of information (eg,
a qualified health care worker checks certain elements of the prescription, such as dosage); RP, resident physician; SC, single check: one qualified health care
worker compares two sources of information (eg, a nurse compares the prescription to the drug label); SP, senior physician. (*) In blue hospital, for the first
prescription of a patient coming the first time, there is a second PR by a SP if patient is treated by a resident physician. (†) In some cantons of Switzerland, only
pharmacies are entitled to dispense drugs (out of inpatient settings). Therefore, in the red hospital’s ambulatory infusion unit, oral chemotherapy is only
prescribed, and the patient then goes to a local pharmacy. (‡) This check is only performed if prescription was entered in CATO. If prescription was entered in
another information technology-system that is also used, there is no check.
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prescriptions of senior physicians were not cross-checked or
reviewed in any of the participating units. Our analysis also
showed that, there was no check in all three hospitals for the
prescription phase of oral chemotherapy on wards (Fig 1D).
Similarly, there were fewer checks for the oral route in the
ambulatory infusion units. In the red hospital, there were no
checks required at all for oral chemotherapy in some cases
from prescription to administration (Figs 1B and 1D). The
number of checks that nurses performed during the ad-
ministration phase varied across different hospitals, even
among the same routes and units (Figs 1A and 1D). The
pharmacist production or preparation phase is the process
that incorporated the most checks along the medication
process. The number of nurse checks during administration
phase varied according to collaborationwith the pharmacy: In
the ambulatory infusion unit of green hospital, the nurses
produced the chemotherapy IV bags onsite. Here, the num-
ber of checks during production and administration was
considerably smaller (three fewer checks) than in the other
hospitals (Fig 1A). In the blue hospital, where the oral che-
motherapy was prepared by the pharmacy, there were more
checks for the oral route than when it was prepared by the
nurses (Fig 1B).
In the green hospital, there was no standardized physician
check before intrathecal administration. The nurses
performed a double check; the physician was supposed to
check thedrug,but itwashisorherownresponsibility (Fig 1C).
Description of Checking Procedures in Internal
Guidelines
The documentation of the pharmacy processes was thorough:
all of the checks performed were documented. In contrast, we
found no internal guidelines to describe any physician checks.
For thenursing tasks, guidelinesoncheckingdrugswere rather
general and not detailed enough to assess specifically which
checks were performed.
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DISCUSSION
Checking chemotherapy before administration or during
preparation is a reasonable action. It is deeply rooted in the
professional self-concept of nurses and pharmacists.
However, our study showed that, for clinicians, there is a lot
of variation and little consistency in the number and types of
checks applied for the same medication phases across hos-
pitals, among different administration routes, and between
units and wards (even within a given hospital). The following
examples illustrate this observation: (1) in the green hospital, a
resident physician prescription was reviewed systematically
by a senior physician when they worked on the ward but not
when they worked in the ambulatory infusion unit. The res-
ident oncologists worked in both places, so this means that
their work was trusted in one place and reviewed in the
other. (2) Given the severe consequences that intrathecal
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administration of a wrong drug may have, it is surprising that
we foundno standardized, systematic checkingprocedure that
involved all participants. (3) The finding that there are fewer
checks fororal chemotherapy is in linewithprior research7 and
points to a need to raise awareness for the hazards in pre-
scription, preparation, and administration of oral chemo-
therapy. Themapping approachwe present is a feasible tool to
identify the discrepancies among administration routes as a
starting point for the design of safer processes. In our opinion,
development of a checklist for intrathecal administrationmay
be a viable way to make the checks before these adminis-
trations more systematic and reliable within and across
hospitals. This would also improve collaboration between
nurses and physicians in this checking situation, especially
because physicians are not as familiar as nurses about
the systematic medication checking procedures according to
our study results. Furthermore, the results illustrate differ-
ent checking habits of the involved professional groups:
Pharmacists have themost standardized checking procedures;
their checks are comparable innumber and type across the two
hospitals (for IV production), and they are transparently
documented in guidelines. Pharmacists worked with the soft-
ware programCATO (BectonDickinson, Franklin Lakes, USA)
for chemotherapy production, which provided technical safety
barriers to avoid, for example, overdoses. For nurses, checking
played an important role in the medication process, but there
was a lot of variation in type andnumberof checkingprocedures
applied among hospitals, units, and routes. Physicians applied
checking procedures only rarely, which may reflect their
autonomy-oriented professional culture andmaybe interpreted
as a sign of their trust in the checks applied by other professions
(eg, the nurses who administer the prescribed chemotherapy).
These differences are important to take into account in the
development of medication safety improvement projects.
The lack or deficiency of descriptions of checking pro-
cedures in the clinician guidelines was surprising to us. We
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expected, for nurse administration of a drug in particular, a
clear indication of what to check and how to perform a check.
This lack of description may explain in part previous findings
that the understanding of an independent check definition is
limited.4
The little consistency of types and numbers of checks also
is a sign that standardization in the design of medication
processes and implemented checkingprocedures is low.Neuss
et al10 published standards for the administration of che-
motherapy thatwere developed by bringing together literature
and expert views to improve the safety of chemotherapy
administration to support the design of safe medication
processes. However, although the standard defines what items
to check, it does not specifically describe the checking pro-
cedure itself (ie, how to perform a good double check). Our
findings about the documentation of checks by clinicians also
pointed to a lack of detail in the definition of checking
procedures. We think that it is important to define and
regularly train professionals about how to perform a double
check (ie, do the two checkers perform a read–read-back
procedure,6 or do they check independently from each
other?). Neuss et al10 recommend use of standards as a basis
for outcome research: when a unit or institution has defined,
specific checking procedures, the effect on error rates can be
monitored and evaluated regularly. In this way, it is possible to
find out whether a specific check or check item, for example,
helps reduce a certain type of medication error.
The nonexistent checks during the prescription phase are
surprising in lightof thehazards thatare involvedinthis step: In
their study on chemotherapy prescription errors, Mattson
et al11 found that, if the involved dosage computation was
complex (eg, was based on glomerular filtration rate and body
surface area), thereweremore prescription errors. In addition,
a lot of information from different sources or systems (eg,
laboratory results or treatment schemes) is used to take the
decisions during the prescription phase. Furthermore, prior
research on interruptions has shown that oncologists are
interrupted frequently during prescribing, which increases the
likelihood of an error.12,13 These factors call for a better design
of the work process to manage existing risks.
We draw as general conclusion from the presented results
that checking procedures are not designed from a holistic
overview of the whole medication process to match existing
hazards. Rather, they seem to be added from individual
professional groups in a fragmented way. For example, when
the pharmacy is involved in production or preparation, there
are considerably more checks than when nurses are in charge;
thus, to fulfill the same tasks, the pharmacy applies more
checks.Giventhat thepharmacyprocessesare lessdisturbedby
interruptions (which is an argument for centralized chemo-
therapy production in the pharmacy) and that the hazards for
the patients remain the same, it is not clear how these dif-
ferences in checks are justified. We highlight the need to ho-
listically analyze and design the oncologic medication process.
For example, to identify areas for improvement in patient safety
in radiation therapy, Chera et al14 applied a safety theory15 that
allowed them to understand the whole work system better.
We focused on existing checks in the medication process, so
our analysis does not allow firm conclusions about missing but
potentially beneficial checks. However, we identified certain
sensitivestepswhenacheckmayhavebeenuseful: forexample,the
patient’sweight is important foraccuratecomputationof thedrug
dosage. The weight is usually entered in the electronic medical
chart by the physician without a check performed afterward,
althoughnurseshave reported incorrectweight entries by chance.
Ananalysis focusedonthechecksthatareconductedalongthe
process only allows for limited conclusions about the safety of the
overall process, because other aspects that determinemedication
safety, such as information technology and work organization or
cultural aspects, are not taken into account. Furthermore, we did
not assess the actual checking behavior, so we cannot draw
conclusions about compliance rates. The results are based on
document analyses and on reports of health professionals who
described their processes, andwemay havemisunderstood some
of the descriptions. However, the fact that each interviewee val-
idated ourmapping results is regarded a signof gooddata quality.
In addition, we did not include actual medication errors or
nearmisses inour study. Linking thenumber, type, andquality
of a check to actual error rates is subject to additional research
(for example, that of Douglass et al1). In conclusion, appli-
cation of a check uses valuable human resources, so adequate
checking procedures should be defined that allow for the best
possible identification of medication errors. The developed
evaluation scheme is important to better understand and
categorize checking activities in everyday practice. The
mapping approach allows for visualization of the checks along
the lifecycle of a prescription and for comparison of them
among hospitals, hospital units, professional groups, and
administration routes. The mapping supports a better un-
derstanding of the checks applied in the whole process, but it
will not guide the decision about when to introduce checks.
The medication hazards should be analyzed carefully, and the
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checks should be located at points in the process that aremost
vulnerable to errors. Human checks have disadvantages dis-
cussed here, so decision makers in hospitals also should con-
sider other safety improvement strategies, such as technologic
support in checking or elimination of hazards by design.16 For
example, rather than implementation of more human checks
to prevent lethal intrathecal applications of vinca alkaloids,
abolishment of the syringe as an administration method and
substitution with small-volume IV bags or use of specific
connection systems that are mechanically incompatible with
intrathecal connectors would be a more robust solution.17
Assessment and comparison of the use of specific safety ac-
tivities, such as checking procedures, generates useful results for
practitioners and researchers alike. The proposed mapping
approach makes the check processes visible to better un-
derstand and improve oncologic practices.
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